Company news: Daiichi Sankyo and GCI Health

Share this article:
Daiichi Sankyo acquired a 140,000 square foot packaging and manufacturing facility in Bethlehem Township, PA for $10 million. The facility “enables DSI to leverage existing resources to more cost-effectively supplement its operations rather than build a new facility,” said the company, which expects the plant to be operational by summer or early fall and to package products including Benicar, Welchol and Azor.

North Shore-LIJ Health System named GCI Health as its PR agency of record. The company operates 15 hospitals in New York City and Long Island.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.

Painkiller maker Acura gets NIH grant

The $300,000 grant will go towards an abuse-deterrent technology.

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.